Risk segmentation related to the offering of a consumer-directed health plan: a case study of Humana Inc

Health Services Research
Laura A TollenStephen Poor

Abstract

To determine whether the offering of a consumer-directed health plan (CDHP) is likely to cause risk segmentation in an employer group. STUDY SETTING AND DATA SOURCE: The study population comprises the approximately 10,000 people (employees and dependents) enrolled as members of the employee health benefit program of Humana Inc. at its headquarters in Louisville, Kentucky, during the benefit years starting July 1, 2000, and July 1, 2001. This analysis is based on primary collection of claims, enrollment, and employment data for those employees and dependents. This is a case study of the experience of a single employer in offering two consumer-directed health plan options ("Coverage First 1" and "Coverage First 2") to its employees. We assessed the risk profile of those choosing the Coverage First plans and those remaining in more traditional health maintenance organization (HMO) and preferred provider organization (PPO) coverage. Risk was measured using prior claims (in dollars per member per month), prior utilization (admissions/1,000; average length of stay; prescriptions/1,000; physician office visit services/1,000), a pharmacy-based risk assessment tool (developed by Ingenix), and demographics. Complete claims and administra...Continue Reading

References

Jan 1, 1988·Journal of Health Politics, Policy and Law·A Enthoven
Jan 1, 1993·Health Affairs·A C Enthoven
May 23, 2001·JAMA : the Journal of the American Medical Association·J C Robinson
Mar 20, 2002·Health Affairs·Debra A DraperBradley C Strunk
Jan 25, 2003·Medical Care·Paul A FishmanMaureen C O'Keeffe Rosetti
Apr 22, 2003·Health Affairs·Jon R GabelThomas Rice
Jun 27, 2003·The New England Journal of Medicine·Elizabeth A McGlynnEve A Kerr
Jul 3, 2004·Health Services Research·Stephen T ParenteJon B Christianson

❮ Previous
Next ❯

Citations

Feb 29, 2008·Health Care Analysis : HCA : Journal of Health Philosophy and Policy·Daniel Simonet
Mar 10, 2010·Maternal and Child Health Journal·Caprice KnappElizabeth Shenkman
Jul 14, 2006·The New England Journal of Medicine·David Blumenthal
Jan 22, 2005·BMJ : British Medical Journal·Martin McKee, Susan Foster
Nov 11, 2008·Health Affairs·Colleen L BarrySusan H Busch
Apr 2, 2009·Pediatrics·Alison A GalbraithTracy A Lieu
Nov 26, 2010·Archives of Internal Medicine·Jeffrey T KullgrenTracy A Lieu
Feb 18, 2016·Health Economics, Policy, and Law·Olivier J WoutersMartin McKee
Apr 22, 2015·Expert Review of Pharmacoeconomics & Outcomes Research·Axel C Mühlbacher
Jul 3, 2004·Health Services Research·Karen Davis
Oct 30, 2010·Health Services Research·Teresa M WatersDavid Mirvis
Jun 10, 2010·Health Services Research·Anthony T Lo SassoBianca K Frogner
Sep 21, 2010·Health Services Research·Judith R LaveYuting Zhang
Apr 7, 2007·Journal of the American College of Radiology : JACR·James W Moser
Nov 26, 2005·Annals of Emergency Medicine·K John McConnell
Feb 25, 2014·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Douglas W RoblinMatthew F Daley
Dec 18, 2012·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Neal Gupta, Daniel Polsky
Apr 12, 2008·Medical Care Research and Review : MCRR·Judith H HibbardMartin Tusler
Jan 5, 2013·American Journal of Health Promotion : AJHP·Paul E Terry
Nov 15, 2005·Health Affairs·Meredith RosenthalArnold Milstein
Jul 10, 2018·Journal of Healthcare Management / American College of Healthcare Executives·David William Jordan
Mar 1, 2006·American Journal of Law & Medicine·Timothy S Jost, Mark A Hall
May 1, 2009·Pediatrics·Paul W NewacheckJames M Perrin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.